Corbus Pharmaceuticals (CRBP) has been on a downward spiral lately with significant selling pressure. After declining 22.7% ...

This was the stock's fourth consecutive day of losses.

Shares of CRBP stock opened at $6.96 on Monday. The firm’s 50-day simple moving average is $9.32 and its 200-day simple moving average is $18.10. Corbus Pharmaceuticals has a 1-year low of $6.38 ...

Shares of CRBP stock opened at $6.79 on Friday. The stock’s 50 day simple moving average is $9.44 and its 200 day simple moving average is $18.99. Corbus Pharmaceuticals has a twelve month low ...

Oppenheimer analyst Jeff Jones reiterated a Buy rating on Corbus Pharmaceuticals (CRBP – Research Report) today and set a price target of ...

RBC Capital analyst Brian Abrahams maintained a Buy rating on Corbus Pharmaceuticals (CRBP – Research Report) yesterday and set a price target ...

Corbus Pharmaceuticals (CRBP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Corbus Pharmaceuticals (CRBP) has been on a downward spiral lately with significant selling pressure. After declining 22.7% over the past four weeks, the stock looks well positioned for a trend ...

This was the stock's second consecutive day of losses.